The team is headed by three pioneers in chimeric antigen receptor (CAR) T-cell therapy development at The University of Pennsylvania’s Perelman School of Medicine: Carl H. June, MD, the Richard W. Vague professor in immunotherapy and director of the Center for Cellular Immunotherapies; Shelley L. Berger, PhD, the Daniel S. Och university professor; and E. John Wherry, PhD, the Richard and Barbara Schiffrin president’s distinguished professor of microbiology and director of the Institute for Immunology. Read more . . .
Stand Up To Cancer, in collaboration with the Lustgarten Foundation for Pancreatic Cancer Research, is supporting a new translational research team that will explore how chimeric antigen receptor T-cell therapy can be applied to pancreatic cancer.